RUNX2 and cleidocranial dysplasia 1: RUNX2-mutant mice exhibit dwarfism and other developmental issues but these effects could be countered by further genetically modifying these animals so that they also lacked miR338. These results suggest that interventions targeting the miR338 pathway could reduce at least some of the developmental defects observed in CCD patients.